CAC
Cowen and Company Portfolio holdings
AUM
$2.9B
This Quarter Return
-16.26%
1 Year Return
+104.28%
3 Year Return
+119.87%
5 Year Return
+632.2%
10 Year Return
–
AUM
$1.01B
AUM Growth
+$1.01B
(+2.1%)
Cap. Flow
+$96.8M
Cap. Flow
% of AUM
9.55%
Top 10 Holdings %
Top 10 Hldgs %
44.9%
Holding
732
New
185
Increased
167
Reduced
131
Closed
135
Top Buys
| 1 |
ARK Innovation ETF
ARKK
|
$60.8M |
| 2 |
Avidity Biosciences
RNA
|
$32.9M |
| 3 |
CUTR
Cutera, Inc.
CUTR
|
$22.4M |
| 4 |
Adicet Bio
ACET
|
$13.8M |
| 5 |
RBAC
RedBall Acquisition Corp.
RBAC
|
$12.5M |
Top Sells
| 1 |
Rivian
RIVN
|
$26.8M |
| 2 |
PMV Pharmaceuticals
PMVP
|
$26.3M |
| 3 |
IPOF
Social Capital Hedosophia Holdings Corp. VI
IPOF
|
$16.6M |
| 4 |
American Express Global Business Travel
GBTG
|
$7.37M |
| 5 |
PFTA
Perception Capital Corp. III Class A Ordinary Share
PFTA
|
$5.92M |
Sector Composition
| 1 | Healthcare | 29.31% |
| 2 | Financials | 13.87% |
| 3 | Materials | 7.41% |
| 4 | Technology | 4.71% |
| 5 | Industrials | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
ARK Innovation ETF
ARKK
$7.45B
| $102M | 9.82% | 2,550,000 +1,525,000 | +149% | +$60.8M |
|
2
Sylvamo
SLVM
$1.86B
| $70.3M | 6.79% | 2,150,000 +195,000 | +10% | +$6.37M |
|
3
Establishment Labs
ESTA
$1.2B
| $45.5M | 4.39% | 836,654 +4,467 | +0.5% | +$243K |
|
|
4
Adicet Bio
ACET
$59.9M
| $35.7M | 3.45% | 2,443,780 +943,725 | +63% | +$13.8M |
|
5
Sumitomo Mitsui Financial
SMFG
$105B
| $33.5M | 3.23% | 5,676,605 | – | – |
|
6
FTAI Aviation
FTAI
$15.8B
| $33.1M | 3.19% | 1,710,550 +224,088 | +15% | +$4.33M |
|
|
7
Avidity Biosciences
RNA
$5.99B
| $32.9M | 3.18% | +2,264,150 | New | +$32.9M |
|
|
CUTR
8
DELISTED
Cutera, Inc.
CUTR
| $22.4M | 2.16% | +596,305 | New | +$22.4M |
|
9
Relmada Therapeutics
RLMD
$37.2M
| $20.3M | 1.96% | 1,066,854 -97,507 | -8% | -$1.85M |
|
10
Stoke Therapeutics
STOK
$1.08B
| $19.9M | 1.93% | 1,509,620 +89,090 | +6% | +$1.18M |
|
|
PSTH
11
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
| $19M | 1.84% | 952,000 +250,000 | +36% | +$4.99M |
|
|
SCPL
12
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $18.8M | 1.82% | 1,346,246 +47,027 | +4% | +$657K |
|
13
Innoviz Technologies
INVZ
$335M
| $18.7M | 1.81% | 4,771,390 +1,388,065 | +41% | +$5.44M |
|
14
Cantaloupe
CTLP
$797M
| $16.6M | 1.6% | 2,963,188 +924,709 | +45% | +$5.18M |
|
15
Apyx Medical
APYX
$75.3M
| $16.5M | 1.59% | 2,818,341 +184,338 | +7% | +$1.08M |
|
|
HCVIU
16
DELISTED
Hennessy Capital Investment Corp. VI Unit
HCVIU
| $14.6M | 1.41% | 1,500,000 | – | – |
|
|
PEGR
17
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
| $14.6M | 1.41% | 1,500,000 | – | – |
|
18
Energy Transfer Partners
ET
$60.8B
| $14.3M | 1.38% | 1,435,000 +280,000 | +24% | +$2.79M |
|
19
Rocket Pharmaceuticals
RCKT
$354M
| $13.8M | 1.33% | 1,000,000 | – | – |
|
|
RBAC
20
DELISTED
RedBall Acquisition Corp.
RBAC
| $12.5M | 1.2% | +1,251,692 | New | +$12.5M |
|
21
Fulcrum Therapeutics
FULC
$351M
| $11.7M | 1.13% | 2,385,885 -1,067,486 | -31% | -$5.23M |
|
|
ADER
22
DELISTED
26 Capital Acquisition Corp. Class A Common Stock
ADER
| $9.81M | 0.95% | 1,000,000 | – | – |
|
|
AVDL
23
Avadel Pharmaceuticals
AVDL
$1.43B
| $9.11M | 0.88% | 3,732,778 | – | – |
|
|
JNCE
24
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $8.62M | 0.83% | 2,843,149 +2,268,814 | +395% | +$6.87M |
|
25
Protagonist Therapeutics
PTGX
$3.67B
| $8.43M | 0.81% | 1,065,724 +343,149 | +47% | +$2.71M |
|